Structure

Physi-Chem Properties

Molecular Weight:  506.22
Volume:  496.11
LogP:  1.691
LogD:  1.524
LogS:  -3.472
# Rotatable Bonds:  9
TPSA:  147.3
# H-Bond Aceptor:  10
# H-Bond Donor:  5
# Rings:  4
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.338
Synthetic Accessibility Score:  4.328
Fsp3:  0.538
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.996
MDCK Permeability:  1.7263249901589006e-05
Pgp-inhibitor:  0.034
Pgp-substrate:  0.995
Human Intestinal Absorption (HIA):  0.049
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.244

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.198
Plasma Protein Binding (PPB):  74.6639633178711%
Volume Distribution (VD):  0.449
Pgp-substrate:  12.806716918945312%

ADMET: Metabolism

CYP1A2-inhibitor:  0.029
CYP1A2-substrate:  0.629
CYP2C19-inhibitor:  0.023
CYP2C19-substrate:  0.781
CYP2C9-inhibitor:  0.039
CYP2C9-substrate:  0.422
CYP2D6-inhibitor:  0.023
CYP2D6-substrate:  0.238
CYP3A4-inhibitor:  0.167
CYP3A4-substrate:  0.603

ADMET: Excretion

Clearance (CL):  6.828
Half-life (T1/2):  0.504

ADMET: Toxicity

hERG Blockers:  0.267
Human Hepatotoxicity (H-HT):  0.218
Drug-inuced Liver Injury (DILI):  0.72
AMES Toxicity:  0.475
Rat Oral Acute Toxicity:  0.06
Maximum Recommended Daily Dose:  0.101
Skin Sensitization:  0.948
Carcinogencity:  0.05
Eye Corrosion:  0.003
Eye Irritation:  0.033
Respiratory Toxicity:  0.643

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC15956

Natural Product ID:  NPC15956
Common Name*:   OZOQXURHSVUEDM-FNMKIYJNSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  OZOQXURHSVUEDM-FNMKIYJNSA-N
Standard InCHI:  InChI=1S/C26H34O10/c1-13-21(29)22(30)23(31)26(35-13)34-12-17-16-9-14(5-4-8-27)10-20(33-3)25(16)36-24(17)15-6-7-18(28)19(11-15)32-2/h6-7,9-11,13,17,21-24,26-31H,4-5,8,12H2,1-3H3/t13-,17-,21-,22+,23+,24+,26+/m0/s1
SMILES:  C[C@H]1[C@@H]([C@H]([C@H]([C@H](OC[C@H]2c3cc(CCCO)cc(c3O[C@@H]2c2ccc(c(c2)OC)O)OC)O1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3581701
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26327 Chaenomeles sinensis Species Rosaceae Eukaryota n.a. n.a. n.a. PMID[14600382]
NPO26327 Chaenomeles sinensis Species Rosaceae Eukaryota Twigs n.a. n.a. PMID[25894905]
NPO26327 Chaenomeles sinensis Species Rosaceae Eukaryota Twigs n.a. n.a. PMID[28358502]
NPO26327 Chaenomeles sinensis Species Rosaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26327 Chaenomeles sinensis Species Rosaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26327 Chaenomeles sinensis Species Rosaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO26327 Chaenomeles sinensis Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT76 Cell Line C6 Rattus norvegicus Activity = 102.88 % PMID[466198]
NPT147 Cell Line SK-MEL-2 Homo sapiens IC50 > 10000.0 nM PMID[466198]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 > 10000.0 nM PMID[466198]
NPT81 Cell Line A549 Homo sapiens IC50 > 10000.0 nM PMID[466198]
NPT148 Cell Line HCT-15 Homo sapiens IC50 > 10000.0 nM PMID[466198]
NPT27 Others Unspecified Activity = 97.4 % PMID[466198]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC15956 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC114505
1.0 High Similarity NPC275284
1.0 High Similarity NPC193473
1.0 High Similarity NPC213074
1.0 High Similarity NPC31325
1.0 High Similarity NPC224674
0.9856 High Similarity NPC476301
0.9856 High Similarity NPC43508
0.9789 High Similarity NPC98624
0.9784 High Similarity NPC471667
0.9784 High Similarity NPC79429
0.9784 High Similarity NPC217635
0.9712 High Similarity NPC185307
0.9712 High Similarity NPC470950
0.965 High Similarity NPC472710
0.965 High Similarity NPC472709
0.9643 High Similarity NPC283995
0.9643 High Similarity NPC470235
0.9643 High Similarity NPC129417
0.964 High Similarity NPC476356
0.964 High Similarity NPC253878
0.9574 High Similarity NPC22150
0.9574 High Similarity NPC38041
0.9574 High Similarity NPC279298
0.9571 High Similarity NPC46092
0.9568 High Similarity NPC471414
0.9568 High Similarity NPC472711
0.951 High Similarity NPC270751
0.9507 High Similarity NPC112861
0.9441 High Similarity NPC39657
0.9437 High Similarity NPC18979
0.9433 High Similarity NPC477898
0.9392 High Similarity NPC228357
0.9366 High Similarity NPC84181
0.9362 High Similarity NPC246947
0.9353 High Similarity NPC470413
0.9353 High Similarity NPC138738
0.931 High Similarity NPC51328
0.931 High Similarity NPC44452
0.931 High Similarity NPC55158
0.931 High Similarity NPC286235
0.9301 High Similarity NPC475096
0.9281 High Similarity NPC10737
0.9281 High Similarity NPC29799
0.9281 High Similarity NPC177035
0.9281 High Similarity NPC52277
0.9281 High Similarity NPC263367
0.9281 High Similarity NPC177160
0.9281 High Similarity NPC477939
0.9281 High Similarity NPC199459
0.9281 High Similarity NPC54743
0.9281 High Similarity NPC209985
0.9281 High Similarity NPC156502
0.9267 High Similarity NPC478269
0.9252 High Similarity NPC302610
0.9247 High Similarity NPC475224
0.9241 High Similarity NPC248132
0.9241 High Similarity NPC130449
0.9236 High Similarity NPC99515
0.9236 High Similarity NPC190714
0.9231 High Similarity NPC164183
0.9231 High Similarity NPC472713
0.9231 High Similarity NPC187774
0.9231 High Similarity NPC473046
0.9231 High Similarity NPC472712
0.9231 High Similarity NPC471063
0.9231 High Similarity NPC118385
0.922 High Similarity NPC106944
0.9209 High Similarity NPC101624
0.9209 High Similarity NPC184938
0.9172 High Similarity NPC227902
0.9167 High Similarity NPC286245
0.9167 High Similarity NPC469586
0.9167 High Similarity NPC272619
0.9161 High Similarity NPC113680
0.9161 High Similarity NPC278961
0.9149 High Similarity NPC156376
0.9145 High Similarity NPC478267
0.9137 High Similarity NPC49603
0.9137 High Similarity NPC187616
0.9137 High Similarity NPC193026
0.9137 High Similarity NPC476411
0.9137 High Similarity NPC187194
0.9122 High Similarity NPC474442
0.9116 High Similarity NPC183380
0.911 High Similarity NPC175976
0.9103 High Similarity NPC125755
0.9103 High Similarity NPC276753
0.9103 High Similarity NPC260397
0.9103 High Similarity NPC205796
0.9097 High Similarity NPC471065
0.9097 High Similarity NPC253015
0.9097 High Similarity NPC25292
0.9097 High Similarity NPC473045
0.9091 High Similarity NPC472714
0.9091 High Similarity NPC189115
0.9091 High Similarity NPC475084
0.9091 High Similarity NPC469559
0.9091 High Similarity NPC131971
0.9091 High Similarity NPC5262
0.9091 High Similarity NPC302506
0.9078 High Similarity NPC304152
0.9071 High Similarity NPC79957
0.9065 High Similarity NPC26394
0.906 High Similarity NPC61604
0.906 High Similarity NPC245615
0.906 High Similarity NPC299706
0.906 High Similarity NPC115466
0.9034 High Similarity NPC180953
0.9034 High Similarity NPC161700
0.9034 High Similarity NPC277867
0.9034 High Similarity NPC307466
0.9028 High Similarity NPC81638
0.9028 High Similarity NPC473044
0.9021 High Similarity NPC263261
0.9021 High Similarity NPC469661
0.9021 High Similarity NPC471908
0.9021 High Similarity NPC87725
0.9007 High Similarity NPC77861
0.9 High Similarity NPC35731
0.9 High Similarity NPC470881
0.9 High Similarity NPC478085
0.9 High Similarity NPC159922
0.8993 High Similarity NPC471505
0.8993 High Similarity NPC106739
0.8993 High Similarity NPC230219
0.8993 High Similarity NPC21902
0.8986 High Similarity NPC214326
0.8986 High Similarity NPC469706
0.8986 High Similarity NPC9933
0.8986 High Similarity NPC260781
0.8986 High Similarity NPC218041
0.8986 High Similarity NPC182368
0.8986 High Similarity NPC469707
0.8986 High Similarity NPC145979
0.8986 High Similarity NPC185955
0.8986 High Similarity NPC225815
0.898 High Similarity NPC474940
0.898 High Similarity NPC303013
0.898 High Similarity NPC130959
0.898 High Similarity NPC166584
0.898 High Similarity NPC304048
0.898 High Similarity NPC301961
0.898 High Similarity NPC71726
0.898 High Similarity NPC226153
0.898 High Similarity NPC159697
0.898 High Similarity NPC474795
0.8966 High Similarity NPC133251
0.8966 High Similarity NPC45257
0.8966 High Similarity NPC179521
0.8966 High Similarity NPC138227
0.8966 High Similarity NPC76176
0.8966 High Similarity NPC12641
0.8966 High Similarity NPC93323
0.8966 High Similarity NPC280092
0.8966 High Similarity NPC469313
0.8966 High Similarity NPC168579
0.8966 High Similarity NPC63879
0.8958 High Similarity NPC41782
0.8958 High Similarity NPC60249
0.8958 High Similarity NPC48309
0.8951 High Similarity NPC184797
0.8951 High Similarity NPC309124
0.8936 High Similarity NPC135777
0.8936 High Similarity NPC142547
0.8933 High Similarity NPC200645
0.8933 High Similarity NPC475227
0.8933 High Similarity NPC106669
0.8929 High Similarity NPC6836
0.8929 High Similarity NPC25821
0.8921 High Similarity NPC248307
0.8921 High Similarity NPC65942
0.8921 High Similarity NPC476345
0.8912 High Similarity NPC15538
0.8912 High Similarity NPC473480
0.8904 High Similarity NPC163898
0.8904 High Similarity NPC181615
0.8897 High Similarity NPC265154
0.8897 High Similarity NPC47633
0.8897 High Similarity NPC252169
0.8897 High Similarity NPC37793
0.8897 High Similarity NPC102044
0.8897 High Similarity NPC85264
0.8889 High Similarity NPC241600
0.8889 High Similarity NPC76871
0.8889 High Similarity NPC173726
0.8882 High Similarity NPC163635
0.8882 High Similarity NPC11411
0.8881 High Similarity NPC88640
0.8881 High Similarity NPC232164
0.8881 High Similarity NPC473739
0.8881 High Similarity NPC212770
0.8881 High Similarity NPC70682
0.8881 High Similarity NPC236306
0.8881 High Similarity NPC292487
0.8881 High Similarity NPC193666
0.8881 High Similarity NPC260741
0.8881 High Similarity NPC98777
0.8881 High Similarity NPC123526
0.8867 High Similarity NPC59692

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC15956 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8759 High Similarity NPD6674 Discontinued
0.8462 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD1613 Approved
0.8272 Intermediate Similarity NPD7228 Approved
0.8252 Intermediate Similarity NPD3027 Phase 3
0.8243 Intermediate Similarity NPD7266 Discontinued
0.8182 Intermediate Similarity NPD1653 Approved
0.8182 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD6234 Discontinued
0.8112 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8112 Intermediate Similarity NPD2861 Phase 2
0.8089 Intermediate Similarity NPD37 Approved
0.8071 Intermediate Similarity NPD1091 Approved
0.8061 Intermediate Similarity NPD7074 Phase 3
0.805 Intermediate Similarity NPD4965 Approved
0.805 Intermediate Similarity NPD4966 Approved
0.805 Intermediate Similarity NPD4967 Phase 2
0.8049 Intermediate Similarity NPD3818 Discontinued
0.8 Intermediate Similarity NPD7054 Approved
0.7974 Intermediate Similarity NPD5058 Phase 3
0.7963 Intermediate Similarity NPD7199 Phase 2
0.7952 Intermediate Similarity NPD7472 Approved
0.7945 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7943 Intermediate Similarity NPD3705 Approved
0.7925 Intermediate Similarity NPD8455 Phase 2
0.7895 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7838 Intermediate Similarity NPD4060 Phase 1
0.7808 Intermediate Similarity NPD4908 Phase 1
0.7758 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7751 Intermediate Similarity NPD7240 Approved
0.7751 Intermediate Similarity NPD6559 Discontinued
0.7751 Intermediate Similarity NPD7251 Discontinued
0.773 Intermediate Similarity NPD1357 Approved
0.7718 Intermediate Similarity NPD3620 Phase 2
0.7718 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD7808 Phase 3
0.7702 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD6797 Phase 2
0.7692 Intermediate Similarity NPD1610 Phase 2
0.7674 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7655 Intermediate Similarity NPD8651 Approved
0.7647 Intermediate Similarity NPD7685 Pre-registration
0.764 Intermediate Similarity NPD1934 Approved
0.7632 Intermediate Similarity NPD5588 Approved
0.7602 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD4538 Approved
0.7566 Intermediate Similarity NPD4536 Approved
0.7566 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7554 Intermediate Similarity NPD5283 Phase 1
0.7552 Intermediate Similarity NPD5126 Approved
0.7552 Intermediate Similarity NPD5125 Phase 3
0.7532 Intermediate Similarity NPD5763 Approved
0.7532 Intermediate Similarity NPD5762 Approved
0.7517 Intermediate Similarity NPD4625 Phase 3
0.75 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6166 Phase 2
0.7485 Intermediate Similarity NPD2978 Approved
0.7485 Intermediate Similarity NPD2977 Approved
0.7457 Intermediate Similarity NPD8312 Approved
0.7457 Intermediate Similarity NPD8313 Approved
0.7451 Intermediate Similarity NPD7097 Phase 1
0.7447 Intermediate Similarity NPD7157 Approved
0.7434 Intermediate Similarity NPD6355 Discontinued
0.7434 Intermediate Similarity NPD5735 Approved
0.741 Intermediate Similarity NPD228 Approved
0.7403 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4108 Discontinued
0.7403 Intermediate Similarity NPD5960 Phase 3
0.7396 Intermediate Similarity NPD2489 Approved
0.7396 Intermediate Similarity NPD27 Approved
0.7389 Intermediate Similarity NPD6331 Phase 2
0.7368 Intermediate Similarity NPD5844 Phase 1
0.7365 Intermediate Similarity NPD5494 Approved
0.7357 Intermediate Similarity NPD7843 Approved
0.7356 Intermediate Similarity NPD7313 Approved
0.7356 Intermediate Similarity NPD7311 Approved
0.7356 Intermediate Similarity NPD7312 Approved
0.7356 Intermediate Similarity NPD7310 Approved
0.7349 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD4749 Approved
0.7337 Intermediate Similarity NPD2969 Approved
0.7337 Intermediate Similarity NPD7680 Approved
0.7337 Intermediate Similarity NPD2970 Approved
0.7324 Intermediate Similarity NPD6671 Approved
0.7321 Intermediate Similarity NPD8127 Discontinued
0.7314 Intermediate Similarity NPD7309 Approved
0.7308 Intermediate Similarity NPD1375 Discontinued
0.7308 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD6696 Suspended
0.7292 Intermediate Similarity NPD1548 Phase 1
0.7289 Intermediate Similarity NPD3882 Suspended
0.7288 Intermediate Similarity NPD7906 Approved
0.7278 Intermediate Similarity NPD3051 Approved
0.7273 Intermediate Similarity NPD2801 Approved
0.7267 Intermediate Similarity NPD3018 Phase 2
0.7266 Intermediate Similarity NPD3022 Approved
0.7266 Intermediate Similarity NPD3021 Approved
0.7255 Intermediate Similarity NPD1558 Phase 1
0.7247 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD7075 Discontinued
0.7232 Intermediate Similarity NPD4663 Approved
0.723 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD5177 Phase 3
0.7208 Intermediate Similarity NPD5124 Phase 1
0.7208 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD6004 Phase 3
0.7197 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD6002 Phase 3
0.7197 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD6005 Phase 3
0.7195 Intermediate Similarity NPD4380 Phase 2
0.7194 Intermediate Similarity NPD2684 Approved
0.7179 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD6071 Discontinued
0.7171 Intermediate Similarity NPD7095 Approved
0.717 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD4110 Phase 3
0.7161 Intermediate Similarity NPD6653 Approved
0.7159 Intermediate Similarity NPD4577 Approved
0.7159 Intermediate Similarity NPD4578 Approved
0.7152 Intermediate Similarity NPD2424 Discontinued
0.7151 Intermediate Similarity NPD7473 Discontinued
0.7143 Intermediate Similarity NPD4140 Approved
0.7126 Intermediate Similarity NPD3817 Phase 2
0.7126 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD2563 Approved
0.7126 Intermediate Similarity NPD2560 Approved
0.7125 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD2677 Approved
0.7124 Intermediate Similarity NPD6798 Discontinued
0.7122 Intermediate Similarity NPD290 Approved
0.7117 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD5327 Phase 3
0.7114 Intermediate Similarity NPD2982 Phase 2
0.7114 Intermediate Similarity NPD2983 Phase 2
0.7107 Intermediate Similarity NPD4236 Phase 3
0.7107 Intermediate Similarity NPD4237 Approved
0.7099 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD6842 Approved
0.7095 Intermediate Similarity NPD6841 Approved
0.7095 Intermediate Similarity NPD6843 Phase 3
0.7086 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD6666 Approved
0.7081 Intermediate Similarity NPD6667 Approved
0.7076 Intermediate Similarity NPD3787 Discontinued
0.7076 Intermediate Similarity NPD6232 Discontinued
0.7072 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD7033 Discontinued
0.7066 Intermediate Similarity NPD5772 Approved
0.7066 Intermediate Similarity NPD1465 Phase 2
0.7066 Intermediate Similarity NPD5773 Approved
0.7066 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD7819 Suspended
0.7063 Intermediate Similarity NPD4628 Phase 3
0.7063 Intermediate Similarity NPD4535 Phase 3
0.7055 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD2981 Phase 2
0.7037 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD1511 Approved
0.7037 Intermediate Similarity NPD7041 Phase 2
0.703 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD3094 Phase 2
0.7019 Intermediate Similarity NPD6190 Approved
0.7013 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7243 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1652 Phase 2
0.7 Intermediate Similarity NPD3060 Approved
0.6994 Remote Similarity NPD1754 Clinical (unspecified phase)
0.6988 Remote Similarity NPD7028 Phase 2
0.6977 Remote Similarity NPD7229 Phase 3
0.6975 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6974 Remote Similarity NPD6584 Phase 3
0.6968 Remote Similarity NPD6233 Phase 2
0.6964 Remote Similarity NPD5929 Approved
0.6959 Remote Similarity NPD4666 Phase 3
0.6959 Remote Similarity NPD5846 Approved
0.6959 Remote Similarity NPD6516 Phase 2
0.6957 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6951 Remote Similarity NPD1512 Approved
0.6951 Remote Similarity NPD7527 Clinical (unspecified phase)
0.6951 Remote Similarity NPD52 Approved
0.6951 Remote Similarity NPD7526 Approved
0.6946 Remote Similarity NPD6072 Discontinued
0.6943 Remote Similarity NPD6353 Approved
0.6933 Remote Similarity NPD1774 Approved
0.6928 Remote Similarity NPD7458 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data